MedPath

YALE UNIVERSITY

YALE UNIVERSITY logo
🇺🇸United States
Ownership
Private
Established
1701-10-09
Employees
10K
Market Cap
-
Website
http://www.yale.edu

Effects of a Comprehensive Weight Management Program on Obese Adolescents and Children

Not Applicable
Completed
Conditions
Pediatric Obesity
Insulin Resistance
Hyperinsulinemia
First Posted Date
2006-12-08
Last Posted Date
2008-06-24
Lead Sponsor
Yale University
Target Recruit Count
200
Registration Number
NCT00409422
Locations
🇺🇸

Yale University School of Medicine, New Haven, Connecticut, United States

Brief Introductory Therapy for Opioid Dependence

Phase 2
Completed
Conditions
Opiate Dependence
HIV Infections
Interventions
Behavioral: BDRC
Behavioral: Standard drug counseling
First Posted Date
2006-12-04
Last Posted Date
2020-04-02
Lead Sponsor
Yale University
Target Recruit Count
51
Registration Number
NCT00406484
Locations
🇺🇸

Methadone Research Unit, The APT Foundation, Inc., New Haven, Connecticut, United States

🇺🇸

Yale University School of Medicine, New Haven, Connecticut, United States

A Study of Everolimus in Combination With Imatinib in Metastatic Melanoma

Phase 2
Terminated
Conditions
Metastatic Melanoma
First Posted Date
2006-11-22
Last Posted Date
2013-12-18
Lead Sponsor
Yale University
Target Recruit Count
3
Registration Number
NCT00402662
Locations
🇺🇸

Yale Comprehensive Cancer Center at Yale University School of Medicine, New Haven, Connecticut, United States

Study of Combination of Sirolimus and Sutent in Patients With Advanced Solid Tumors Non-Curable With Standard Therapy

Phase 1
Terminated
Conditions
Tumors
Interventions
First Posted Date
2006-11-22
Last Posted Date
2013-12-18
Lead Sponsor
Yale University
Target Recruit Count
18
Registration Number
NCT00402415
Locations
🇺🇸

Yale Comprehensive Cancer Center at Yale University School of Medicine, New Haven, Connecticut, United States

A Trial of Extracorporeal Photopheresis, Pentostatin, and Total Body Irradiation in Patients Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation for the Treatment of Malignancies

Phase 2
Completed
Conditions
Hematologic Malignancies
Interventions
Procedure: extracorporeal photopheresis
Radiation: Total Body Irradiation
First Posted Date
2006-11-22
Last Posted Date
2017-01-18
Lead Sponsor
Yale University
Target Recruit Count
14
Registration Number
NCT00402714
Locations
🇺🇸

Yale Comprehensive Cancer Center at Yale University School of Medicine, New Haven, Connecticut, United States

🇺🇸

Tufts-New England Medical Center, Boston, Massachusetts, United States

🇺🇸

Methodist Hospital - Texas Transplant Institute, San Antonio, Texas, United States

Expression of Mif Alleles in Individuals With Leishmaniasis

Completed
Conditions
Leishmaniasis
First Posted Date
2006-11-20
Last Posted Date
2020-03-30
Lead Sponsor
Yale University
Target Recruit Count
438
Registration Number
NCT00401349
Locations
🇨🇴

Centro Internacional de Entrenamiento e Investigaciones Medicas, CIDEIM, Cali, Colombia

Mechanisms Relating to the Distinct in Vitro Susceptibility of Human Macrophages to L. Viannia Infection

Completed
Conditions
Leishmaniasis
First Posted Date
2006-11-20
Last Posted Date
2020-03-30
Lead Sponsor
Yale University
Target Recruit Count
34
Registration Number
NCT00401557
Locations
🇨🇴

Centro Internacional de Entrenamiento e Investigaciones Medicas, CIDEIM, Cali, Colombia

Th1/Th2 Polarization and Linkage to L. Viannia Infection Outcomes

Completed
Conditions
Leishmaniasis
First Posted Date
2006-11-20
Last Posted Date
2020-03-30
Lead Sponsor
Yale University
Target Recruit Count
122
Registration Number
NCT00401297
Locations
🇨🇴

Centro Internacional de Entrenamiento e Investigaciones Medicas, CIDEIM, Cali, Colombia

Recovery Guide Intervention for Recurrent Psychiatric Hospitalization

Not Applicable
Completed
Conditions
Schizophrenia
Schizoaffective Disorder
Bipolar Disorder
Psychotic Depression
Interventions
Behavioral: Recovery Mentor
First Posted Date
2006-11-16
Last Posted Date
2009-06-12
Lead Sponsor
Yale University
Target Recruit Count
71
Registration Number
NCT00400166
Locations
🇺🇸

Yale-New Haven Psychiatric Hospital, New Haven, Connecticut, United States

HIV Risk Reduction and Drug Abuse Treatment in Iran

Phase 2
Withdrawn
Conditions
Opiate Dependence
HIV Infections
Interventions
Drug: Buprenorphine/Subutex
Behavioral: Drug counseling
First Posted Date
2006-11-10
Last Posted Date
2020-03-30
Lead Sponsor
Yale University
Registration Number
NCT00398008
Locations
🇺🇸

Yale University School of Medicine, New Haven, Connecticut, United States

🇮🇷

Institute for Cognitive Studies, Tehran, Iran, Islamic Republic of

© Copyright 2025. All Rights Reserved by MedPath